To celebrate Ophthalmology Times' 50th anniversary, we asked leading experts what the practice would look like today had ...
D-150 demonstrated consistent and durable benefit across all three patient cohorts as evidenced by maintenance of visual acuity, control of ...
The Korea Research Institute of Standards and Science (KRISS) has developed a retina-mimicking eye phantom that faithfully ...
4D Molecular Therapeutics (4DMT) released positive interim 1.5- to 3.5-year data from the phase 1/2 PRISM clinical trial ...
Voiant, a leader in clinical trial imaging solutions, is pleased to announce the publication of a new peer-reviewed study in Diagnostics as part of the Special Issue Updates on the Diagnosis and ...
Robotic palpation for in situ tissue biomechanical evaluation is crucial for disease diagnosis, especially in luminal organs. However, acquiring ...
View the full release here: "With a similar safety profile, OPN can be a feasible and faster alternative to IVL." Dr. M. Bossard, Senior Physician at Luzerner Kantonsspital, Switzerland A total of ...
“In people who have diabetes, when they’re on GLP-1s, they experience an early increase in the risk of diabetic retinopathy,” ...
UK research finds that AI could be used to limit unnecessary treatment of AMD patients and increase capacity for those at risk of losing sight ...
Avisi Technologies, Inc., an ophthalmic medical device company advancing novel, sight-saving technologies, presented positive twelve-month clinical data on VisiPlate® Aqueous Shunt from the VITA Trial ...
In patients with suspected MI with no obstructed coronary arteries, a stratified treatment protocol was superior to standard ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback